Increase/Decrease in Cash: The total change in cash for the company over the given period.
Thermo Fisher Scientific Inc. (TMO) had Increase/Decrease in Cash of $132.00M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$10.36B |
|
$1.51B |
|
$6.06B |
|
$4.31B |
|
$8.65B |
|
$1.72B |
|
$-97.00M |
|
$1.62B |
|
$1.62B |
|
$1.52B |
|
$1.51B |
|
$1.51B |
|
$1.52B |
|
$1.72B |
|
-- |
|
378.00M |
|
379.00M |
|
$3.99 |
|
$3.98 |
|
| Balance Sheet Financials | |
$23.38B |
|
$9.33B |
|
$75.66B |
|
$99.04B |
|
$13.17B |
|
$31.37B |
|
$36.51B |
|
$49.68B |
|
-- |
|
$-12.46B |
|
$49.36B |
|
-- |
|
| Cash Flow Statement Financials | |
$723.00M |
|
$-527.00M |
|
$-102.00M |
|
$4.04B |
|
$4.17B |
|
|
Increase/Decrease in Cash |
$132.00M |
-- |
|
$-149.00M |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|